• Seeking Alpha

Statement of total voting rights and shares forming the company’s share capital as October 20, 2025

Seeking Alpha / 3 hours from now 1 Views

 Article R. 22-10-23 of the French Commercial Code
 Market : Euronext Paris
ISIN code / Mnemo : FR0013233012 / IVA
Web site : www.inventivapharma.com

Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
Combined General Meeting of November 27, 2025 - Availability of the preparatory documents
Next post
Information relative au nombre total de droits de vote et d’actions composant le capital social au 20 octobre 2025

Comments

Just Posted

  • Xanadu Advances to Stage B of DARPA’s Quantum Benchmarking Initiative, Securing up to $15 Million in Funding

    4 hours from now

  • Maxim Power Corp. Announces 2025 Third Quarter Financial and Operating Results

    4 hours from now

  • BRT Apartments Corp. Files Third Quarter 2025 Financial Statements

    4 hours from now

  • Petrus Resources Announces Third Quarter 2025 Financial & Operating Results

    4 hours from now

  • Optiva Inc. Reports Third Quarter 2025 Financial Results

    4 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1937

Categories

  • Seeking Alpha 1937

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts